Skip to main content

Table 4 Comparison of the AUROC values between the inflammation-based index and grade

From: A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

period

AUC(95%CI)

P value

overall

 dNLR

0.649(0.603–0.694)

< 0.001

 PNI

0.571(0.525–0.618)

0.003

 dNLR-PNI

0.685(0.633–0.724)

< 0.001

 BCLC

0.659(0.611–0.702)

< 0.001

1-year

 dNLR

0.637(0.597–0.676)

< 0.001

 PNI

0.579(0.539–0.62)

< 0.001

 dNLR-PNI

0.695(0.646–0.724)

< 0.001

 BCLC

0.739(0.684–0.761)

< 0.001

3-year

 dNLR

0.634(.590–0.677)

< 0.001

 PNI

0.574(0.530–0.618)

0.001

 dNLR-PNI

0.679(0.635–0.720)

< 0.001

 BCLC

0.652(0.609–0.684)

< 0.001

5-year

 dNLR

0.645(0.600–0.691)

< 0.001

 PNI

0.572(0.525–0.618)

0.003

 dNLR-PNI

0.683(0.639–0.737)

< 0.001

 BCLC

0.594(0.542–0.648)

< 0.001

  1. dNLR derived neutrophil-to-lymphocyte ratio, PNI prognostic nutritional index, BCLC barcelona clinic liver cancer
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us